Legal & General Group’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.9M | Buy |
249,120
+43,927
| +21% | +$512K | ﹤0.01% | 1812 |
|
2025
Q1 | $1.52M | Buy |
205,193
+96,563
| +89% | +$717K | ﹤0.01% | 2021 |
|
2024
Q4 | $651K | Buy |
108,630
+97,798
| +903% | +$586K | ﹤0.01% | 2372 |
|
2024
Q3 | $55.5K | Buy |
10,832
+1,011
| +10% | +$5.18K | ﹤0.01% | 2780 |
|
2024
Q2 | $35.6K | Sell |
9,821
-93,095
| -90% | -$337K | ﹤0.01% | 2844 |
|
2024
Q1 | $330K | Buy |
102,916
+4,819
| +5% | +$15.5K | ﹤0.01% | 2580 |
|
2023
Q4 | $481K | Sell |
98,097
-340
| -0.3% | -$1.67K | ﹤0.01% | 2469 |
|
2023
Q3 | $536K | Sell |
98,437
-698
| -0.7% | -$3.8K | ﹤0.01% | 2406 |
|
2023
Q2 | $665K | Buy |
99,135
+3,474
| +4% | +$23.3K | ﹤0.01% | 2362 |
|
2023
Q1 | $845K | Buy |
95,661
+1,353
| +1% | +$11.9K | ﹤0.01% | 2194 |
|
2022
Q4 | $721K | Buy |
94,308
+1,569
| +2% | +$12K | ﹤0.01% | 2241 |
|
2022
Q3 | $660K | Sell |
92,739
-25,225
| -21% | -$180K | ﹤0.01% | 2268 |
|
2022
Q2 | $954K | Buy |
117,964
+27,325
| +30% | +$221K | ﹤0.01% | 2179 |
|
2022
Q1 | $1.26M | Buy |
90,639
+1,757
| +2% | +$24.4K | ﹤0.01% | 2157 |
|
2021
Q4 | $2.49M | Buy |
88,882
+418
| +0.5% | +$11.7K | ﹤0.01% | 1921 |
|
2021
Q3 | $3.01M | Buy |
88,464
+15,773
| +22% | +$536K | ﹤0.01% | 1812 |
|
2021
Q2 | $2.97M | Buy |
72,691
+15,960
| +28% | +$652K | ﹤0.01% | 1798 |
|
2021
Q1 | $2.28M | Buy |
56,731
+1,073
| +2% | +$43.2K | ﹤0.01% | 1925 |
|
2020
Q4 | $3.29M | Sell |
55,658
-9,669
| -15% | -$572K | ﹤0.01% | 1681 |
|
2020
Q3 | $3.18M | Buy |
65,327
+31,731
| +94% | +$1.54M | ﹤0.01% | 1563 |
|
2020
Q2 | $1.63M | Buy |
33,596
+12,354
| +58% | +$598K | ﹤0.01% | 1809 |
|
2020
Q1 | $589K | Buy |
21,242
+19,730
| +1,305% | +$547K | ﹤0.01% | 2024 |
|
2019
Q4 | $45K | Buy |
1,512
+656
| +77% | +$19.5K | ﹤0.01% | 2849 |
|
2019
Q3 | $26K | Buy |
+856
| New | +$26K | ﹤0.01% | 3029 |
|